Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY). (Q33602180)

28 July 2017

title

Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY). (English)

1 reference

28 July 2017

1 reference

2

1 reference

28 July 2017

9

Philippe Froguel

0 references

Nadia Cobo-Vuilleumier

object named as

Nadia Cobo-Vuilleumier

Maria Adelaida Garcia-Gimeno

3

0 references

object named as

Maria Garcia-Gimeno

11

0 references

author name string

Antonio L Cuesta-Muñoz

1

1 reference

28 July 2017

Hanna Koskela

4

1 reference

28 July 2017

Stella Odili

5

1 reference

28 July 2017

Amanda Stride

6

1 reference

28 July 2017

Carol Buettger

7

1 reference

28 July 2017

Timo Otonkoski

8

1 reference

28 July 2017

Joseph Grimsby

10

1 reference

28 July 2017

Franz M Matschinsky

12

1 reference

28 July 2017

language of work or name

English

0 references

publication date

10 November 2009

1 reference

28 July 2017

1 reference

28 July 2017

volume

33

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

290-292

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

28 July 2017

copyright license

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Assessing the potential of glucokinase activators in diabetes therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

Allosteric activators of glucokinase: potential role in diabetes therapy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

The genetic abnormality in the beta cell determines the response to an oral glucose load

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2809268

30 October 2018

Identifiers

DOI

10.2337/DC09-0681

1 reference

28 July 2017

1 reference

28 July 2017

1 reference